Stenhouse Mark — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Stenhouse Mark has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Stenhouse Mark

Mark Stenhouse is identified in Phathom Pharmaceuticals, Inc.'s SEC filings as of May 21, 2026. His exact title and role are not specified in the provided context. He appears in the SEC filing context as an insider associated with Phathom Pharmaceuticals, a biotechnology company. Alternative name ordering (e.g., Mark Stenhouse vs. Stenhouse Mark) may appear in different filings. No additional public biographical details are available in this context.

RoleInsider
Notability28/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-21PHATPhathom Pharmaceuticals, Inc.A — Grant or award24.1K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Stenhouse Mark?

Mark Stenhouse is identified in Phathom Pharmaceuticals, Inc.'s SEC filings as of May 21, 2026. His exact title and role are not specified in the provided context. He appears in the SEC filing context as an insider associated with Phathom Pharmaceuticals, a biotechnology company. Alternative name ordering (e.g., Mark Stenhouse vs. Stenhouse Mark) may appear in different filings…

How many SEC Form 4 filings has Stenhouse Mark submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Stenhouse Mark's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Stenhouse Mark profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.